Skip to content
Search

Latest Stories

PDA sets pay claim for its member working for Boots pharmacy

The Pharmacists’ Defence Association (PDA)'s pay negotiations on behalf of its members working for Boots will take place this week. The association has set out 12 points following the feedback received from its members in annual pay and condition survey, covering pay growth, fairness and work/life balance.

This is the first of a number of meetings to take place during the summer aimed at reaching an agreement in time for an increase to be paid from November 01 2021.


More than 1,000 members participated in PDA's annual pay and conditions survey. Many concerns were raised by the members about pay. 

Paul Moloney, PDA Union National Officer, thanked members for completing the survey. He said: “It is always important that we are able to demonstrate that we are reflecting the views of members and with such a high response rate no one can deny this claim is the claim members have shaped and supported.”

According to the survey, 84 per cent of pharmacists do not understand or are unhappy with their reward package; 97 per cent of them would be unhappy or find it unacceptable if no pay increase were awarded this year; 84 per cent supported an RPI +2 per cent increase for this year or a multi-year agreement of inflation plus increases over the next 3 years.

Whereas 85 per cent have little or no idea on how to progress their salary through the market range; 84 per cent are not aware that they can request an in-year salary review; 94 per cent believe experience should be reflected in salary; and 99 per cent expressed the view that a premium should be paid for working on a bank holiday.

As a result of this feedback, the PDA Union has produced a detailed, evidence-based and objectively benchmarked claim calling for an increase of inflation plus 2 per cent for this year and, in response to the clear support from members for a multi-year deal, the alternative of a 3 year deal with increases of inflation plus 2 per cent in year one and inflation plus 1.5 per cent in years two and three.

Paul Moloney commented: It remains to be seen how the company responds to the concept of a multi-year deal, but it is quite clear from the feedback from members that a repeat of last year would be completely unacceptable. The company needs to have in place a strategy to ensure the purchasing power of members’ pay starts to catch up with what has been lost not just last year but in preceding years. Our claim is a serious attempt to assist the company in this.

In total the PDA's claim includes the following 12 points covering pay growth, pay fairness and work/life balance issues raised during the consultation.

  1. To reduce the erosion of pharmacists’ salaries an increase of RPI + 2% in FY2021/22. The feedback received from the bargaining unit showed enthusiasm for a multi-year deal, so we would be keen to discuss this option (RPI +1.5% FY2022/23 and RPI+1.5% FY2023/24).
  2. To continue the differential set by Boots in August 2020 for those pharmacists that qualified in Aug 2019. All pharmacists should receive a £1000 increment on August 1st in the year following registration. This should retrospectively include pharmacists who entered the provisional register in August 2020 and subsequently the full register in April 2021.
  3. In line with pay progression principles, all pharmacists who have been in role 2 years+ should have their current salary reviewed.
  4. In areas where location enhancements are being paid to encourage recruitment, a location ‘retainer’ should be paid to current Boots pharmacists to encourage retention.
  5. Pharmacists should receive a payment of £300 for completing new and subsequent refresher training e.g. Gateway.
  6. The threshold hours at which Extra Duty (ED) will be paid at premium rate should be reduced to 40 hours. There would be no change to the current guidance for pharmacists whose employment started before August 2007.
  7. All time worked beyond threshold limit should be paid at contracted premium rate. This would include designated company training which cannot be completed during work time.
  8. In line with the Company Pay Progression Principles, a salary review should be undertaken for all pharmacists at 5-year intervals. This would not exclude an individual pharmacist from requesting an interim review.
  9. A premium payment of x1.5 for working on a bank holiday.
  10. Pharmacists should be notified which bank holidays they will be expected to work when holidays are confirmed by PDP.
  11. Pharmacists should be notified 12 weeks in advance of the bank holiday of the location of the store they will be working in.
  12. Pharmacists should not be placed in an unfamiliar store on a bank holiday.

PDA said: "Members are reminded this is the claim for improvements. The company will respond in due course with its proposals."

Paul concluded: “We have set out a claim that reflects members’ views, is fair and evidenced-based. We hope the company will make an offer that reflects the need to address the issues we have raised and with the intention of reaching an early agreement.”

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less